Skin cancer screening behaviours among individuals with a strong family history of malignant melanoma

British Journal of Cancer

Volumn 103, Issue 10, 2010, Pages 1502-1509

  Kasparian, N A ^a   McLoone, J K ^a   Meiser, B ^b,c   Butow, P N ^d   Simpson, J M ^e   Mann, G J ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

anxiety; clinical skin examination; family history; genetics; melanoma; skin self examination

Indexed keywords

ADULT; ANXIETY; ARTICLE; CANCER RISK; CANCER SCREENING; CLINICAL EFFECTIVENESS; DEMOGRAPHY; DEPRESSION; FAMILY HISTORY; FEMALE; HEREDITY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SKIN CANCER; SKIN EXAMINATION; SUN EXPOSURE;

ATTITUDE TO HEALTH; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EDUCATIONAL STATUS; FAMILY; FEMALE; HUMANS; LEARNING; MALE; MARITAL STATUS; MEDICAL HISTORY TAKING; MELANOMA; MUTATION; PERCEPTION; PREVALENCE; SELF-EXAMINATION; SKIN; SKIN NEOPLASMS;

EID: 78149471150     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605942     Document Type: Article

References (44)

1. Aitken JF, Duffy DL, Green A, Youl P, MacLennan R, Martin NG (1994) Heterogeneity of melanoma risk in families of melanoma patients. Am J Epidemiol 140: 961-973
2. Aspinwall L, Leaf S, Dola E, Kohlmann W, Leachman S (2008) CDKN2A/ p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families. Cancer Epidemiol Biomarkers Prev 17: 1510-1519
3. Australian Cancer Network (2008) Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. National Health and Medical Research Council (NHMRC): Canberra
4. Australian Institute of Health and Welfare Australasian Association of Cancer Registries (2004) Cancer in Australia 2001. AIHW (Cancer Series No. 28): Canberra
5. Berwick M, Armstrong BK, Ben-Porat L, Fine J, Kricker A, Eberle C, Barnhill R (2005) Sun exposure and mortality from melanoma. J Natl Cancer Inst 97: 195-199
6. Berwick M, Begg CB, Fine J, Roush GC, Barnhill RL (1996) Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 88: 17-23
7. Bishop D, Demenais F, Goldstein A, Bergman W, Newton Bishop J, Bressac-dePaillerets B, Chompret A, Ghiorzo P, Gruis N, Hansson J, Harland M, Hayward N, Holland E, Mann G, Mantelli M, Nancarrow D, Platz A, Tucker M, Consortium TMG (2002) Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 94: 894-903
8. Brady MS, Oliveria SA, Christos PJ, Berwick M, Coit DG, Katz J, Halpern AC (2000) Patterns of detection in patients with cutaneous melanoma. Cancer 89: 342-347
9. Cannon-Albright L, Meyer L, Goldgar D, Lewis C, McWhorter W, Jost M, Harrison D, Anderson D, Zone J, Skolnick M (1994) Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res 54: 6041-6044
10. Carli P, De Giorgi V, Palli D, Maurichi A, Mulas P, Orlandi C, Imberti GL, Stanganelli I, Soma P, Dioguardi D, Catricala C, Betti R, Cecchi R, Bottoni U, Bonci A, Scalvenzi M, Giannotti B, Italian Multidisciplinary Group on Melanoma (2003) Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma. Arch Dermatol 139: 607-612
11. Cella D, Mahon SM, Donovan M (1990) Cancer recurrence as a traumatic event. Behav Med 16: 15-22
12. Easton DF, Cox GM, Macdonald AM, Ponder BA (1991) Genetic susceptibility to naevi: a twin study. Br J Cancer 64: 1164-1167
13. Folkman S, Guer S (2000) Promoting psychological well-being in the face of serious illness: when theory, research and practice inform each other. Psychooncology 9: 11-19
14. Geller A, Emmons K, Brooks D, Zhang Z, Powers C, Koh H, Sober A, Miller D, Li F, Haluska F, Gilchrest B (2003) Skin cancer prevention and detection practices among siblings of patients with melanoma. J Am Acad Dermatol 49: 631-638
15. Gillanders E, Juo S, Holland E, Jones M, Nancarrow D, Freas-Lutz D, Sood R, Park N, Faruque M, Markey C, Kefford R, Palmer J, Bergman W, Bishop D, Tucker M, Bressac-de Paillerets B, Hansson J, Stark M, Gruis N, Bishop J, Goldstein A, Bailey-Wilson J, Mann G, Hayward N, Trent J, Group LMS, Consortium MG (2003) Localization of a novel melanoma susceptibility locus to 1p22. Am J Hum Genet 73: 301-313
16. Glanz K, Rimer BK, Lewis FM (2002) Health Behaviour and Health Education. Theory, Research and Practice. Wiley & Sons: San Fransisco
17. Goldstein A, Chan M, Harland M, Gillanders E, Hayward N, Avril M-F, Azizi E, Bianchi-Scarra F, Bishop D, Bressac-de Paillerets B, Bruno W, Calista D, Cannon-Albright L, Demenais F, Elder D, Ghiorzo P, Gruis N, Hansson J, Hogg D, Holland E, Kanetsky P, Kefford R, Landi MT, Lang J, Leachman SA, MacKie R, Magnusson V, Mann GJ, Niendorf K, Newton Bishop J, Palmer J, Puig S, Puig-Butille J, de Snoo FA, Stark M, Tsao H, Tucker M, Whitaker L, Yakobson E, The Lund Melanoma Study Group, and The Melanoma Genetics Consortium (GenoMEL) (2006) Assessment of high-risk melanoma susceptibility genes and their associations with pancreatic cancer, neural system tumors, and uveal melanoma: A Melanoma Genetics Consortium (GenoMEL) Study. Cancer Res 66: 9818-9828
18. Goldstein A, Falk R, Fraser M, Dracopoli N, Sikorski R, Clark WJ, Tucker M (1998) Sun-related risk factors in melanoma-prone families with CDKN2A mutations. J Natl Cancer Inst 90: 709-711
19. Hayward N (2003) Genetics of melanoma predisposition. Oncogene 22: 3053-3062
20. Holland E, Schmid H, Kefford R, Mann G (1999) CDKN2A (p16INK4a) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas. Genes Chromosomes Cancer 25: 339-348
21. Horowitz M, Wilner N, Alvarez W (1979) The impact of event scale: a measure of subjective stress. Psychosom Med 41: 209-218
22. Hosmer DW, Lemeshow S (2000) Applied Logistic Regression. 2nd edn. Wiley & Sons, Inc: Toronto
23. Kasparian N, Butow P, Meiser B, Mann G (2008) High- and average-risk individuals' beliefs about, and perceptions of, malignant melanoma: an Australian perspective. Psychooncology 17: 270-279
24. Kasparian N, McLoone J, Butow P (2009a) Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol 145: 1415-1427
25. Kasparian N, Meiser B, Butow P, Job R, Mann G (2007) Anticipated uptake of genetic testing for familial melanoma in an Australian sample: an exploratory study. Psychooncology 16: 69-78
26. Kasparian N, Meiser B, Butow P, Simpson J, Mann G (2009b) Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families. Genet Med 11: 265-278
27. Kefford R, Mann G (2003) Is there a role for genetic testing in patients with melanoma? Curr Opin Oncol 15: 157-161
28. Kleinbaum D, Kupper L, Muller K (1987) Applied Regression Analysis and Other Multivariate Methods. 2nd edn. PWS-KENT: Boston
29. Liang K, Zeger S (1986) Longitudinal data analysis using generalised linear models. Biometrika 73: 13-22
30. Manne S, Fasanella N, Connors J, Floyd B, Wang H, Lessin S (2004) Sun protection and skin surveillance practices among relatives of patients with malignant melanoma: Prevalence and predictors. Prev Med 39: 36-47
31. Manne S, Lessin S (2006) Prevalence and correlates of sun protection and skin self-examination practices among cutaneous malignant melanoma survivors. J Behav Med 29: 419-434
32. McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF (2006) Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol 54: 783-792
33. Miller S (1987) Monitoring and blunting: validation of a questionnaire to assess styles of information seeking under threat. J Pers Soc Psychol 52: 345-353
34. Miller SM (1996) Monitoring and blunting of threatening information: cognitive interference and facilitation in the coping process. In Cognitive Interference: Theories, Methods, and Findings, Sarason I, Pierce G, Sarason B (eds), pp 175-190.
35. Lawrence Erlbaum Associates: Hillsdale, NJ, England Muris P, Schouten E (1994) Monitoring and blunting: a factor analysis of the Miller Behavioural Style Scale. Pers Ind Dif 17: 285-287
36. Myers RE, Turner B, Weinberg D, Hyslop T, Hauck WW, Brigham T, Rothermel T, Grana J, Schlackman N (2004) Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. Prev Med 38: 375-381
37. Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Berwick M, Halpern AC (2004) Patient adherence to skin self-examination: effect of nurse intervention with photographs. Am J Prev Med 26: 152-155
38. Palmer J, Duffy D, Box N, Aitken J, O'Gorman L, Green A, Hayward N, Martin N, Sturm R (2000) Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 66: 176-186
39. Rimer BK, Trock B, Engstrom PF, Lerman C, King E (1991) Why do some women get regular mammograms? Am J Prev Med 7: 69-74
40. Robinson J, Fisher S, Turrisi R (2002) Predictors of skin self-examination performance. Cancer 95: 135-146
41. Tracey E, Baker D, Chen W, Stavrou E, Bishop J (2007) Cancer in New South Wales: Incidence, Mortality and Prevalence 2005. Cancer Institute NSW: Sydney
42. Tucker M, Fraser M, Goldstein A, Elder D, Guerry 4th D, Organic S (1993) The risk of melanoma and other cancers in melanoma-prone families. J Invest Dermatol 100: 350S-355S
43. Van Der Velden P, Sandkuijl L, Bergman W, Pavel S, Van Mourik L, Frants R, Gruis N (2001) Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 69: 774-779
44. Zigmond A, Snaith R (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67: 361-370